Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
15-18 September, 2025
Not Confirmed
Not Confirmed
15-18 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
15-18 September, 2025
Industry Trade Show
Not Confirmed
15-18 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
15 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/innovent-to-present-multiple-rd-results-of-general-biomedicine-pipeline-at-the-34th-eadv-congress-2025-302556355.html
10 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/10/3147536/0/en/Fangzhou-and-Innovent-Biologics-Form-Strategic-Alliance-for-AI-Powered-Weight-Management-Solutions.html
27 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/innovent-announces-2025-interim-results-and-business-updates-302539881.html
25 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/innovent-biologics-announces-us-fda-ind-approval-for-the-first-global-mrct-phase-3-study-marslight-11-of-ibi363-pd-1il-2-bias-in-squamous-non-small-cell-lung-cancer-302537159.html
04 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/innovent-receives-us-fda-approval-for-ind-application-of-oral-glp-1r-agonist-ibi3032-302520701.html
16 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nature-medicine-published-phase-1-results-of-innovent-biologics-anti-cldn18-2-adc-ibi343-in-patients-with-advanced-gastricgastroesophageal-junction-adenocarcinoma-302506844.html
ABOUT THIS PAGE